Lessons learned from a pediatric clinical trial: The Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study

American Heart Journal

Volumn 161, Issue 2, 2011, Pages 233-240

  Li, Jennifer S ^a   Colan, Steven D ^b   Sleeper, Lynn A ^b   Newburger, Jane W ^c   Pemberton, Victoria L ^d   Atz, Andrew M ^e   Cohen, Meryl S ^f   Golding, Fraser ^g   Klein, Gloria L ^b   Lacro, Ronald V ^c   Radojewski, Elizabeth ^g   Richmond, Marc E ^h   Minich, L Luann ⁱ  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; EQUIPOISE; FEASIBILITY STUDY; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD, PRESCHOOL; EARLY TERMINATION OF CLINICAL TRIALS; ENALAPRIL; HUMANS; MITRAL VALVE INSUFFICIENCY;

EID: 79851491310     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.10.030     Document Type: Article

References (30)

1. Lee P.Y., Alexander K.P., and Hammill B.G. Representation of elderly persons and women in published randomized trials of acute coronary syndromes JAMA 286 2001 708 713 (Pubitemid 33010364)
2. Heiat A., Gross C.P., and Krumholz H.M. Representation of the elderly, women, and minorities in heart failure clinical trials Arch Intern Med 162 2002 1682 1688
3. Shah S.S., Hall M., and Goodman D. Off-label drug use in hospitalized children Arch Pediatr Adolesc Med 161 2007 282 290 (Pubitemid 46364332)
4. Pasquali S.K., Hall M., and Slonim A.D. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease Circ Cardiovasc Qual Outcomes 1 2008 74 83
5. Mahony L., Sleeper L.A., and Anderson P.A. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease Pediatr Cardiol 27 2006 191 198
6. Hanley F.L., Fenton K.N., and Jonas R.A. Surgical repair of complete atrioventricular canal defects in infancy. Twenty-year trends J Thorac Cardiovasc Surg 106 1993 387 394 [discussion 394-7]
7. Moran A.M., Daebritz S., and Keane J.F. Surgical management of mitral regurgitation after repair of endocardial cushion defects: early and midterm results Circulation 102 19 Suppl 3 2000 III 160 III 165
8. Crawford F.A. Jr, and Stroud M.R. Surgical repair of complete atrioventricular septal defect Ann Thorac Surg 72 2001 1621 1628 [discussion 1628-9]
9. Michielon G., Stellin G., and Rizzoli G. Repair of complete common atrioventricular canal defects in patients younger than four months of age Circulation 96 9 Suppl 1997 II-316 II-322
10. Ten Harkel A.D., Cromme-Dijkhuis A.H., and Heinerman B.C. Development of left atrioventricular valve regurgitation after correction of atrioventricular septal defect Ann Thorac Surg 79 2005 607 612 (Pubitemid 40186567)
11. Pisacane C., Pacileo G., and Santoro G. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy Ital Heart J 2 2001 100 106 (Pubitemid 32303444)
12. Gaasch W.H., and Aurigemma G.P. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation J Am Coll Cardiol 39 2002 1380 1383 (Pubitemid 34297881)
13. Wisenbaugh T., Sinovich V., and Dullabh A. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation J of Heart Valve Dis 3 1994 197 204 (Pubitemid 24096143)
14. Calabro R., Pisacane C., and Pacileo G. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation Am Heart J 138 5 Pt 1 1999 955 961 (Pubitemid 29523285)
15. Gupta D.K., Kapoor A., and Garg N. Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study J Heart Valve Dis 10 2001 158 165 (Pubitemid 32243696)
16. Seguchi M., Nakazawa M., and Momma K. Effect of enalapril on infants and children with congestive heart failure Cardiol Young 2 1992 14 19
17. Bonow R.O., Carabello B., and de Leon A.C. ACC/AHA guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) J Heart Valve Dis 7 1998 672 707
18. Zoghbi W.A., Enriquez-Sarano M., and Foster E. Recommendations for the evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiog 16 2003 777 802 (Pubitemid 37391035)
19. Rendell J.M., and Licht R.W. Under-recruitment of patients for clinical trials: an illustrative example of a failed study Acta Psychiatr Scand 115 2007 337 339 (Pubitemid 46570058)
20. Gajewski B.J., Simon S.D., and Carlson S.E. Predicting accrual in clinical trials with Bayesian posterior predictive distributions Stat Med 17 2008 2328 2340 (Pubitemid 351802897)
21. Freedman B. Equipoise and the ethics of clinical research N Engl J Med. 317 1987 141 145 (Pubitemid 17092151)
22. Alharthi M.S., Mookadam F., and Tajik A.J. Echocardiographic quantitation of mitral regurgitation Expert Rev Cardiovasc Ther 6 2008 1151 1160
23. Patel A.R., Mochizuki Y., and Yao J. Mitral regurgitation: comprehensive assessment by echocardiography Echocardiography 17 2000 275 283 (Pubitemid 30225420)
24. Cuzzolin L., Atzei A., and Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety Expert Opin Drug Safety 5 2006 703 718 (Pubitemid 44322888)
25. Roberts R., Rodriguez W., and Murphy D. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies JAMA 290 2003 905 911 (Pubitemid 37430462)
26. Benjamin D.K. Jr, Smith P.B., and Murphy M.D. Peer-reviewed publication of clinical trials completed for pediatric exclusivity JAMA 296 2006 1266 1273 (Pubitemid 44394898)
27. McCrindle B.W., Zak V., and Sleeper L.A. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure Circulation 121 2010 34 42
28. Williams I.A., Sleeper L.A., and Colan S.D. Functional state following the Fontan procedure Cardiol Young 15 2009 1 11
29. Anderson P.A., Sleeper L.A., and Mahony L. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study J Am Coll Cardiol 52 2008 85 98 (Pubitemid 351885451)
30. Lacro R.V., Dietz H.C., and Wruck L.M. Rationale and design of a randomized clinical trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome Am Heart J 154 2007 624 631 (Pubitemid 47429596)